Inventor · disambiguated record
Ellen Garber
Also filed as: GARBER ELLEN · GARBER ELLEN A
35 granted patents·30 pending applications·581 citations·filing 1999–2022
98Inventor score
Top patents by PatentIndex Score
65 records- 0198US7863419B2Antibodies having altered effector function and methods for making the sameBIOGEN IDEC INC·Filed 2006·Granted Jan 4, 2011·140 cites·88 claims
- 0296US8128926B2Sp35 antibodies and uses thereofMI SHA·Filed 2009·Granted Mar 6, 2012·29 cites·20 claims
- 0395US8784823B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2012·Granted Jul 22, 2014·38 cites·7 claims
- 0495US8293237B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofBURKLY LINDA C·Filed 2008·Granted Oct 23, 2012·40 cites·19 claims
- 0595US7799902B2Receptor coupling agents and compositions thereofBIOGEN IDEC INC·Filed 2006·Granted Sep 21, 2010·29 cites·41 claims
- 0694US7612178B2Anti-IGF-1R antibodies and uses thereofBIOGEN IDEC INC·Filed 2007·Granted Nov 3, 2009·24 cites·16 claims
- 0793US9598484B2Human anti-tau antibodiesBIOGEN MA INC·Filed 2013·Granted Mar 21, 2017·18 cites·182 claims
- 0893US8147829B2Anti-IGR-1R antibodies and uses thereofHARIHARAN KANDASAMY·Filed 2009·Granted Apr 3, 2012·41 cites·22 claims
- 0993US7358054B2Antibodies to VLA-1BIOGEN IDEC INC·Filed 2002·Granted Apr 15, 2008·37 cites·25 claims
- 1091US7910099B2Antibodies to VLA-1BIOGEN IDEC INC·Filed 2010·Granted Mar 22, 2011·12 cites·17 claims
- 1190US8609407B2Sp35 antibodies and uses thereofMI SHA·Filed 2012·Granted Dec 17, 2013·6 cites·18 claims
- 1289US7723073B2Antibodies to VLA-1BIOGEN IDEC INC·Filed 2008·Granted May 25, 2010·10 cites·17 claims
- 1387US8669345B2Nogo receptor antagonistsLEE DANIEL H S·Filed 2007·Granted Mar 11, 2014·16 cites·3 claims
- 1487US6897297B1Hydrophobically-modified protein compositions and methodsBIOGEN IDEC INC·Filed 2000·Granted May 24, 2005·21 cites·51 claims
- 1585US8318917B2Nucleic acids encoding antibodies having altered effector function and methods for making the sameTAYLOR FREDERICK R·Filed 2010·Granted Nov 27, 2012·10 cites·77 claims
- 1684US8618252B2Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related theretoFARRINGTON GRAHAM K·Filed 2010·Granted Dec 31, 2013·8 cites·17 claims
- 1784US8410061B2Functional antagonists of hedgehog activityWILLIAMS KEVIN·Filed 2002·Granted Apr 2, 2013·11 cites·41 claims
- 1884US8084028B2Antibodies to VLA-1KARPUSAS MICHAEL·Filed 2011·Granted Dec 27, 2011·8 cites·21 claims
- 1984US8021661B2Cripto binding moleculesBIOGEN IDEC INC·Filed 2007·Granted Sep 20, 2011·5 cites·29 claims
- 2083US7947271B2Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agentsBIOGEN IDEC INC·Filed 2010·Granted May 24, 2011·6 cites·32 claims
- 2182US7405277B2Antibodies against monocyte chemotactic proteinsBIOGEN IDEC INC·Filed 2004·Granted Jul 29, 2008·10 cites·6 claims
- 2281US8048422B2Tweak binding antibodiesBIOGEN IDEC INC·Filed 2007·Granted Nov 1, 2011·7 cites·4 claims
- 2381US7429644B2Humanized anti-LT-β-R antibodiesBIOGEN IDEC INC·Filed 2003·Granted Sep 30, 2008·9 cites·33 claims
- 2480US7888479B2Humanized antibodies against monocyte chemotactric proteinsBIOGEN IDEC INC·Filed 2003·Granted Feb 15, 2011·4 cites·46 claims
- 2580US2023135399A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 2679US9321840B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2014·Granted Apr 26, 2016·2 cites·15 claims
- 2777US7972597B2Methods of reducing chemotaxis using antibodies against monocyte chemotactic proteinsBIOGEN IDEC INC·Filed 2009·Granted Jul 5, 2011·1 cites·1 claims
- 2877US7632501B2Antibodies against monocyte chemotactic proteinsBIOGEN IDEC INC·Filed 2008·Granted Dec 15, 2009·1 cites·29 claims
- 2976US9228015B2Nogo receptor antagonists and methods of increasing neurite outgrowthBIOGEN IDEC INC·Filed 2014·Granted Jan 5, 2016·2 cites·5 claims
- 3075US8431125B2Methods of treating lupus nephritis using antibodies against monocyte chemotactic proteinsDE FOUGEROLLES ANTONIN R·Filed 2011·Granted Apr 30, 2013·2 cites·26 claims
- 3175US7429645B2Humanized anti-lymphotoxin beta receptor antibodiesBIOGEN IDEC INC·Filed 2004·Granted Sep 30, 2008·5 cites·23 claims
- 3274US9738707B2Heterodimeric Fc regions, binding molecules comprising same, and methods relating theretoTAYLOR FREDERICK R·Filed 2012·Granted Aug 22, 2017·2 cites·33 claims
- 3372US8519112B2Humanized antibodies against monocyte chemotactic proteinsDE FOUGEROLLES ANTONIN R·Filed 2011·Granted Aug 27, 2013·1 cites·9 claims
- 3468US2009054632A1Hydrophobically-modified protein compositions and methodsBIOGEN IDEC INC·Filed 2007·Application pending·0 cites
- 3566US7479539B1Hedgehog fusion proteinsCURIS INC·Filed 2000·Granted Jan 20, 2009·3 cites·39 claims
- 3666US2019233530A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB BIOPHARMA SPRL·Filed 2019·Application pending·0 cites
- 3765US6444793B1Hydrophobically-modified hedgehog protein compositions and methodsCURIS INC·Filed 1999·Granted Sep 3, 2002·23 cites·27 claims
- 3865US2013287796A1Sp35 Antibodies and Uses ThereofBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 3963US9096665B2Antibodies against monocyte chemotactic proteinsBIOGEN IDEC INC·Filed 2013·Granted Aug 4, 2015·0 cites·26 claims
- 4063US2005119181A1Hydrophobically-modified protein compositions and methodsCURIS INC·Filed 2004·Application pending·0 cites
- 4162US2006275283A1Fcgamma receptor-binding polypeptide variants and methods related theretoBIOGEN IDEC INC·Filed 2006·Application pending·0 cites
- 4261US2015315273A1SP35 Antibodies And Uses ThereofBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 4360US2014079697A1Humanized antibodies against monocyte chemotactic proteinsBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 4459US2012003235A1Anti-lymphotoxin antibodiesRANGER ANN M·Filed 2009·Application pending·0 cites
- 4559US2009092601A1HUMANIZED ANTI-LT-beta-R ANTIBODIESBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 4658US2008124278A1Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereofTAYLOR FREDERICK R·Filed 2007·Application pending·0 cites
- 4758US2015017155A1Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereofBIOGEN IDEC INC·Filed 2014·Application pending·0 cites
- 4858US2016200823A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB PHARMA SA·Filed 2016·Application pending·0 cites
- 4956US2016185846A1Antibodies against monocyte chemotactic proteinsBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 5055US2012177638A1Antibodies to vla-1KARPUSAS MICHAEL·Filed 2011·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →